Sutro Biopharma appoints Sukhi Jagpal to Board of Directors and Audit Committee

SUTRO BIOPHARMA, INC.

Sukhi Jagpal appointed as Class III director effective August 8, 2024, and to Audit Committee effective August 15, 2024.
Jagpal receives pro rata portions of $40,000 director retainer and $10,000 Audit Committee retainer for remainder of year.
Granted stock options: 35,000 shares (3-year monthly vest) and 28,959 shares (vesting until 2025 annual meeting).
Standard indemnification agreement entered; no family relationships or material transactions with existing officers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sukhi Jagpal

Director

STRO · SUTRO BIOPHARMA, INC.

Effective: 2024-08-08
Filed: August 12, 2024, 7:59 PM ET

On August 8, 2024, the board of directors (the “ Board ”) of Sutro Biopharma, Inc. (the “ Company ”) appointed Sukhi Jagpal, as a Class III director, effective as of August 8, 2024, and as a member of the Audit Committee, effective as of August 15, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sukhi Jagpal was appointed as Director at SUTRO BIOPHARMA, INC..

Action: appointed
Role: Director

Exact text from the filing

On August 8, 2024, the board of directors (the “ Board ”) of Sutro Biopharma, Inc. (the “ Company ”) appointed Sukhi Jagpal, as a Class III director, effective as of August 8, 2024, and as a member of the Audit Committee, effective as of August 15, 2024.

View on SEC.gov

SUTRO BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0000950170-24-095486

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.